C$0.84 0.0 0.0%
Last Trade - 08/04/21
| Market Cap | £24.6m |
| Enterprise Value | £23.4m |
| Revenue | £6.57m |
| Position in Universe | 1240th / 2707 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.59 | 4.90 | 6.76 | 5.99 | 8.68 | 11.2 | +33.9% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Aurora Spine Corporation is a Canada-based holding company. The Company's segment includes its focus on the development and sale of minimally invasive, interspinous fusion systems and devices. The Company's interspinous process (ISP) lumbar fusion devices include the ZIP and ZIP ULTRA, the ZIP LP and the ZIP-51. In addition, the Company offers a line of interbody products, such as the TiNano product line, including EOS, Echo and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. Its product lines include ISP lumbar fusion devices; polyether ether ketone (PEEK) interbody cages, and Stand-alone (SA) Cervical and Lumbar devices. Its interbody cage products are used to fill the space between vertebrae after degenerative disc material has been removed. Its VOX is a minimally invasive lateral lumbar interbody fusion (LLIF) system featuring TiNano titanium spray coating technology. It characterizes business in the United States and outside the United States.
| Last Annual | December 31st, 2019 |
| Last Interim | June 30th, 2020 |
| Incorporated | July 4, 2013 |
| Public Since | September 10, 2013 |
| No. of Shareholders: | n/a |
| No. of Employees: | 13 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | TSX Venture Exchange |
| Shares in Issue | 50,365,817 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 20 HOLLY STREET SUITE 300, TORONTO, M4S 3B1, Canada |
| Web | https://auroraspine.us/ |
| Phone | +1 760 4242004 |
| Contact | () |
| Auditors | MNP LLP |
As of 08/04/21, shares in Aurora Spine are trading at C$0.84, giving the company a market capitalisation of £24.6m. This share price information is delayed by 15 minutes.
Shares in Aurora Spine are currently trading at C$0.84 and the price has moved by 0.500k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Aurora Spine price has moved by 0.339k% over the past year.
Of the analysts with advisory recommendations for Aurora Spine, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Aurora Spine is Not available. You can view the full broker recommendation list by unlocking its StockReport.
Aurora Spine is scheduled to issue upcoming financial results on the following dates:
Aurora Spine does not currently pay a dividend.
Aurora Spine does not currently pay a dividend.
Aurora Spine does not currently pay a dividend.
To buy shares in Aurora Spine you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Aurora Spine are currently trading at C$0.84, giving the company a market capitalisation of £24.6m.
Here are the trading details for Aurora Spine:
Based on an overall assessment of its quality, value and momentum, Aurora Spine is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for Aurora Spine.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aurora Spine. Over the past six months, the relative strength of its shares against the market has been 0.140k%. At the current price of C$0.84, shares in Aurora Spine are trading at 0.129k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Aurora Spine.
Aurora Spine's management team is headed by:
Here are the top five shareholders of Aurora Spine based on the size of their shareholding:
